FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

425555004: Haemophilus influenzae Type b + tetanus vaccine (product)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2020. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    2663062018 Haemophilus influenzae Type b + tetanus vaccine (product) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT core
    2675077013 Haemophilus influenzae Type b + tetanus vaccine en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core
    4203931000005111 Haemophilus influenzae type B- + tetanusvaccine da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Haemophilus influenzae type B- + tetanusvaccine Is a tetanusvaccine false Inferred relationship Some
    Haemophilus influenzae type B- + tetanusvaccine Is a Haemophilus influenzae type b-vaccine false Inferred relationship Some
    Haemophilus influenzae type B- + tetanusvaccine The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. tetanustoxoid false Inferred relationship Some
    Haemophilus influenzae type B- + tetanusvaccine The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. vaccine mod Haemophilus influenzae type B false Inferred relationship Some 1
    Haemophilus influenzae type B- + tetanusvaccine The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. tetanusvaccine false Inferred relationship Some 2
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Haemophilus influenzae type b-polysaccharidvaccine 10 µg + tetanustoxoid 30 µg pulver til injektionsvæske, opløsning, hætteglas + solvens Is a False Haemophilus influenzae type B- + tetanusvaccine Inferred relationship Some
    Haemophilus influenzae type B-polysaccharidvaccine 10 µg + tetanustoxoid 24 µg Is a False Haemophilus influenzae type B- + tetanusvaccine Inferred relationship Some
    difteri- + tetanus- + Haemophilus influenzae type b-vaccine Is a False Haemophilus influenzae type B- + tetanusvaccine Inferred relationship Some
    Haemophilus b polysaccharide 10micrograms/tetanus toxoid 30micrograms powder for conventional release solution for injection vial Is a False Haemophilus influenzae type B- + tetanusvaccine Inferred relationship Some

    Reference Sets

    Concept inactivation indicator reference set

    POSSIBLY EQUIVALENT TO association reference set (foundation metadata concept)

    Back to Start